CSI-UCSF 2018 , United States of America - Home


October 26 – 27, 2018
San Francisco, USA

CSI-UCSF 2018 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease - CSI-UCSF 2018 CSI-UCSF 2018 Catheter Interventions in Congenital, Structural and Valvar Heart Disease
CSI-UCSF 2018 , United States of America

CSI-UCSF
October 26 – 27, 2018
San Francisco, USA



Please subscribe to our
csi pfeil
newsletter

Add to my calendar

CSI-UCSF 2018 Topics Scientific Program CSI-UCSF Workshops New Users Course Scientific Faculty Registration Abstracts & Cases Key Information Supporters Archive Event Calendar
Fontsize bigger
  CSI-UCSF 2018 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease
CSI-UCSF 2018 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease

Board of Directors

Gareth Morgan, MD

University of Colorado
Denver
USA

Board of Directors: Gareth Morgan, MD
More

Gareth Morgan, MD

University of Colorado
Denver, USA

Board of Directors: Gareth Morgan, MD
Gareth Morgan was appointed as a consultant congenital interventional cardiologist at Evelina Children’s Hospital and Guys and St Thomas’ hospital in London in June 2013.

Gareth’s subspecialty fellowship in interventional congenital cardiology was carried out with Dr Lee Benson at the Hospital for Sick Children, Toronto, Ontario 2008-2010.

He was first appointed consultant paediatric and adult congenital cardiologist at University Hospitals Bristol in 2010 and has been an honorary senior lecturer at the University of Bristol since 2011.

Gareth's undergraduate and early postgraduate training was at The Queens University of Belfast and the Royal Belfast Hospital for Sick Children.

Here he also completed his MPhil research thesis in paediatric cardiology before SpR training in paediatric and adult congenital cardiology at University Hospitals Bristol.

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt
Germany

Board of Directors: Horst Sievert, MD
More

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt, Germany

Board of Directors: Horst Sievert, MD
Director and Founder of CVC Frankfurt

Specialist in Internal Medicine, Cardiology, Angiology, and Intensive Care

Medical degree from Johannes Gutenberg University Mainz and Johann Wolfgang Goethe University Frankfurt, Germany

Dr. Sievert has been the Principal Investigator of a number of clinical trials and has authored more than 130 manuscripts and 600 abstracts in peer reviewed journals, as well as 70 books and book contributions. He has also delivered more than 600 invited lectures around the world.
 
He has personally performed more than 16,000 PCIs and 6,000 peripheral angioplasties. However, his activity in the cath lab is focused on highly specialized non-coronary interventions for patients with congenital heart disease, carotid disease, or high risk of stroke, among other conditions. Dr Sievert was the first to close the left atrial appendage percutaneously. He has the largest experience worldwide in catheter closure of heart defects in adults and gets referrals from all over the world.

Randy Lee, MD

University of California
San Francisco
USA

Board of Directors: Randy Lee, MD
More

Randy Lee, MD

University of California
San Francisco, USA

Board of Directors: Randy Lee, MD
Education
1984 UCLA School of Medicine 

Residencies
1988 Harbor-UCLA Medical Center, Internal Medicine
 
Fellowships
1991 Stanford University Medical Center, Cardiovascular Diseases 

Dr. Randall J. Lee graduated from UCLA Medical School in 1984 where he also obtained his doctorate in pharmacology. After completing an internal medicine residency at Harbor-UCLA Medical Center in Torrance, Calif., he completed a cardiology fellowship and postdoctoral fellowship in biochemistry and molecular biology at Stanford University, where he earned a Physician Scientist Award and the Upjohn Young Investigator Award in cardiology. Lee subspecialized in cardiac electrophysiology during his second fellowship at UCSF.
His research focuses on cellular and molecular aspects of cardiac arrhythmias and vascular regeneration. He is investigating the cellular and molecular derangements that occur during cardiac arrhythmias and myocardial infarctions. Lee uses genetic engineering techniques to investigate derangements during cardiac arrhythmias and myocardial infarctions and as possible therapeutic tools. Lee also is interested in cardiac development of the conduction system and the means to alter conduction, which then may be applied to diseased states.

Vaikom Mahadevan, MD

University of California
San Francisco
USA

Board of Directors: Vaikom Mahadevan, MD

Director Emeritus

Neil Wilson, MD


Oxford
UK

Director Emeritus: Neil Wilson, MD

Invited Faculty

Theodore P. Abraham, MD

University of California
San Francisco
USA

Invited Faculty: Theodore P. Abraham, MD
More

Theodore P. Abraham, MD

University of California
San Francisco, USA

Invited Faculty: Theodore P. Abraham, MD
Theodore P. Abraham, M.D. is the Meyer Friedman Distinguished Professor of Medicine, Clinical Chief of Cardiology and Director of Echocardiography at the University of California at San Francisco. Until July 2017 he was Professor of Medicine, and Radiology and Radiologic Science at Johns Hopkins University in Baltimore, Maryland where he directed the Johns Hopkins Hospital Echocardiography Programs and founded and directed the Johns Hopkins Hypertrophic Cardiomyopathy Center of Excellence. He was also Associate Dean for Research for Johns Hopkins Medicine. His primary clinical expertise is echocardiography with a focus on cardiac mechanics. He has published over 100 scientific papers, held national leadership positions in professional societies and serves on editorial boards of biomedical journals.

Zahid Amin, MD

Children’s Hospital of Georgia Regents University
Augusta
USA

Invited Faculty: Zahid Amin, MD
More

Zahid Amin, MD

Children’s Hospital of Georgia Regents University
Augusta, USA

Invited Faculty: Zahid Amin, MD
PRESENT POSITION

Professor of Pediatrics
Chief, Division of Pediatric Cardiology, Children’s Hospital of Georgia, Georgia Regents University, Augusta, GA
FAAP, FSCAI, FACC, FAHA

ACADEMIC APPOINTMENTS
  • 2008 – today Professor of Pediatrics, Director of Cardiac Catheterization & Hybrid Suite, Rush University Medical Center
  • 2006 - 2008 Professor of Pediatrics, University of Nebraska Medical Center
  • 2000 - 2008 Associate Professor of Pediatrics, University of Nebraska Medical Center
  • 2004 - 2008 Associate Clinical Professor of Pediatrics, Creighton University School of Medicine
  • 2000 - 2004 Assistant Clinical Professor of Pediatrics, Creighton University School of Medicine
  • 1998 - 1999 Assistant Professor in Pediatric Cardiology, Medical College of Georgia
CERTIFICATIONS
  • Diplomate, American Board of Pediatrics, January 1996
  • Diplomate, Sub-board of Pediatric Cardiology, August 2002
CONSULTING POSITIONS (active)
  • 2000 – Present The Nebraska Medical Center, Omaha, Nebraska
  • 2000 – 2008 Children’s Hospital, Omaha, Nebraska
HONORS AND AWARDS
  • Session Chair. 4th World Congress of Pediatric Cardiology and Cardiac Surgery.  Buenos Aires, Argentina. 20 Sep 2005.
  • Elected to Honorary Membership in the Russian Scientific Society of Interventional Radiology and Endovascular Surgery. June 2005
  • Best Paper, Awarded by Midwest Pediatric Cardiology Society, 2000.
  • Fellow of the Year, Awarded by Midwest Pediatric Cardiology Society, 1997 – 1998.
  • Outstanding Fellow, Denton A. Cooley Cardiovascular Surgery Society, 1990 – 1992.





                                                                                                                     

Jason Anderson, MD

Mayo Clinic College of Medicine
Rochester
USA

Invited Faculty: Jason Anderson, MD
More

Jason Anderson, MD

Mayo Clinic College of Medicine
Rochester, USA

Invited Faculty: Jason Anderson, MD
Jason Anderson graduated from the University of Iowa Carver College Of Medicine in 2011. He went on to complete his education in Pediatrics and Pediatric Cardiology at Mayo Clinic where he has been appointed to the position of Assistant Professor of Pediatrics in the Mayo School of Graduate Medical Education since 2016. He is now undergoing additional training in pediatric and congenital interventional cardiology under the mentorship of Dr. Philip Moore at UCSF and will return to practice at Mayo Clinic upon completion. Specific interests include transcatheter valve implantation, device closure of septal defects, and intracardiac echocardiography.

Nitish Badhwar, MD

University of California San Francisco
San Francisco
USA

Invited Faculty: Nitish Badhwar, MD

Stefan Bertog, MD

CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Minneapolis Medical Center, Minneapolis
USA

Invited Faculty: Stefan Bertog, MD
More

Stefan Bertog, MD

CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Minneapolis Medical Center, Minneapolis, USA

Invited Faculty: Stefan Bertog, MD
Specialist in Cardiology, Angiology and Interventional Cardiology at CVC Frankfurt since February 2013

  • Since 2006 Assistant Professor, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
  • 2010 - Present Co-Director of Cardiac Catheterization Laboratory, Veterans Administration Hospital, Minneapolis, Minnesota, USA
  • 2006 - Present Cardiologist, Veterans Administration Hospital, Minneapolis, Minnesota, USA
  • 2003 - 2005 Chief Fellow Cardiology,, University of Minnesota, Minneapolis, Minnesota, USA
  • 2002 - 2006 Fellowship, Cardiology and Interventional Cardiology at University of Minnesota, Minneapolis, USA
  • 1999 - 2002 Residency, Internal Medicine at the Cleveland Clinic Hospital, Cleveland, Ohio, USA
  • 1997 - 1998 Junior Physician, Department of Cardiology at Municipal Hospital in Frankfurt Höchst, Germany
  • 1990 - 1997 Medical Degree at Johann Gutenberg University in Mainz, Germany







Ramin E. Beygui, MD

University of California San Francisco
San Francisco
United States of America

Invited Faculty: Ramin E. Beygui, MD

Todd Brinton, MD

Stanford University
Stanford
USA

Invited Faculty: Todd Brinton, MD
More

Todd Brinton, MD

Stanford University
Stanford, USA

Invited Faculty: Todd Brinton, MD
Todd Brinton is a Clinical Associate Professor of Medicine (Cardiology) and Consulting Associate Professor of Bioengineering at Stanford University. He is an attending interventional cardiologist at both Stanford University Medical Center and the Palo Alto VA Medical Center. He has served as the Innovation Fellowship Director for Stanford Biodesign since 2005 and also co-directs the Stanford graduate course series in Biodesign Innovation.

Dr. Brinton lectures on strategies for innovation and serves as a mentor to innovation fellows, graduate students, and executives. His academic research focuses on the process of innovation for development of novel medical technologies. He specifically focuses on the integration of research and development for new technologies with the clinical strategy and pre-clinical evaluation. He has served as a clinical investigator for a number to studies of interventional-based therapies for chronic ischemia heart disease and heart failure.

Dr. Brinton completed his medicine, cardiology, and interventional cardiology training at Stanford University. He holds an MD from the Chicago Medical School and a BS in Bioengineering from the University of California, San Diego. He is Co-Founder and Board Director for Shockwave Medical and BioParadox, Inc., which are both venture-backed medical device companies in the cardiovascular space. He also serves on the board of directors of Qool Therapeutics and Infogard Laboratories. In addition, he serves on the advisory board of a number of early-stage medical device companies, where he focuses on clinical development and strategy. Prior to medical school, he was the Clinical Research Director for Pulse Metric, Inc., a venture-backed medical device start-up company.

Maurice Buchbinder, MD

Foundation for Cardiovascular Medicine
San Diego
USA

Invited Faculty: Maurice Buchbinder, MD

John Carroll, MD

University of Colorado Hospital
Aurora
USA

Invited Faculty: John Carroll, MD
More

John Carroll, MD

University of Colorado Hospital
Aurora, USA

Invited Faculty: John Carroll, MD
Dr. Carroll received his AB (biology) cum laude from Princeton University in 1972 and his MD (Alpha Omega Alpha) from the University of Chicago in 1976.  He at Tufts New England Medical Center from 1976-1981 finishing as the Samuel Levine Cardiology Research Fellow of the American Heart Association. He then was a cardiology research fellow at Universittaetspital in Zurich, Switzerland. From 1982-1996 he was a member of the faculty at the University of Chicago Pritzker School of Medicine and directed the Hans Hecht Cardiac Catheterization Laboratory. He and his partner, Ted Feldman, started performing aortic and mitral valvuloplasties together starting in 1985. In 1996 he moved to the University of Colorado as Professor of Medicine, Director of Interventional Cardiology, and Co-Medical Director of the Cardiac and Vascular Center.  He has developed the interventional program at the University of Colorado with his partner, John Messenger.

He is currently a member of various national and international editorial and advisory boards, the STS-ACC Transcatheter Valve Therapy Registry Steering Committee, and the Steering Committee of the RESPECT trials.
 
Dr. Carroll is an interventional cardiologist with clinical and investigative interests related to structural/valvular heart disease interventions and the development of advanced cardiac 3D imaging for image guidance. He has collaborated with James Chen, PhD, for over 25 years. Dr. Carroll has co-edited with John G. Webb, MD of Vancouver the first textbook on “Structural Heart Disease Interventions”.

Mao Chen, MD

West China Hospital of Sichuan University
Chengdu, Sichuan
China

Invited Faculty: Mao Chen, MD

Tony Chou, MD

The Vertical Group
San Francisco
United States of America

Invited Faculty: Tony Chou, MD

Paolo Denti, MD

San Raffaele University Hospital
Milan
Italy

Invited Faculty: Paolo Denti, MD
More

Paolo Denti, MD

San Raffaele University Hospital
Milan, Italy

Invited Faculty: Paolo Denti, MD
Responsible of transcatheter therapy for mitral disease as Hybrid Cardiovascular Surgeon since 9/2013 in the Heart Surgery Dept at San Raffaele Hospital, Milan. Adjunct Professor for “Hybrid Cardiac Surgery” and for Master in Interventional Cardiology since 9/2014 at University Vita e Salute, Milan.
Hydrid training in surgical theatre (Prof. Alfieri) and Cath Lab (Prof. Colombo). ESC Fellow and EACTS Member.
Expert Mitraclip implanter (more 100 cases/year). Implanter of 1st Tiara (percutaneous mitral valve) in Italy (2nd Europe). 23/03/2016). 3rd Operator at FIM (First in man) implantation of the first percutaneous annuloplasty band (Cardioband) in 2013 in San Raffaele and Percutaneous Tricuspid valve repair (Tricinch) (2014). Expert on Minimally invasive mitral valve repair included Neochord Transapical implantation, TAVI  (TF, Tap, Tao) either valve in valve mitral and aortic and valve in ring procedures.
Author and co-author of more than 50 papers on peer reviewed journals and book chapters. Honoured of the podium in all renewed international congresses. Involved in sperimental animal surgery and in development of new cardiac devices.
Core interests in innovations, new percutaneous approach to structural heart disease (in particular mitral valve repair and aortic valve implantation), pre-clinical animal/bench study for development of new cardiac devices.

Tobias Deuse, MD

University of California San Francisco
San Francisco
USA

Invited Faculty: Tobias Deuse, MD
More

Tobias Deuse, MD

University of California San Francisco
San Francisco, USA

Invited Faculty: Tobias Deuse, MD
Tobias Deuse, M.D. is a cardiac surgeon internationally renowned for his expertise in minimally-invasive mitral valve surgery. He earned an M.D. from University of Wuerzburg in 2000. Dr. Deuse thereafter received advanced training in cardiothoracic surgery at the University Hospital Munich-Grosshadern, the University Heart Center Hamburg-Eppendorf, and Stanford University. He achieved international acclaim for the development of innovative approaches for mitral valve surgery and demonstrated that high success rates can be achieved in endoscopic mitral valve repair even for complex valve pathologies. He is the Director for Minimally-invasive Cardiac Surgery at UCSF.

Gansevoort Dunnington, MD

St Helena Hospital
St. Helena
USA

Invited Faculty: Gansevoort Dunnington, MD

Danny Dvir, MD

University of Washington
Seattle
USA

Invited Faculty: Danny Dvir, MD
More

Danny Dvir, MD

University of Washington
Seattle, USA

Invited Faculty: Danny Dvir, MD
Danny Dvir has large experience in structural heart interventions. He is the president of the board of the Institute of Valvular Research and is internationally recognized as an expert in evaluating and treating prosthetic heart valves, including valve-in-valve therapy. Dr. Dvir was trained in Internal Medicine and Cardiology in Israel. Subsequently, he had Cardiac Interventions fellowship training in in Washington DC and later on worked extensively and specialized in non-invasive strategies for the treatment of heart valves in the Center for Heart Valve Innovation in Vancouver, BC. Dr. Dvir is a faculty in the University of Washington.

Marvin Eng, MD

Henry Ford Hospital
Detroit
USA

Invited Faculty: Marvin Eng, MD
More

Marvin Eng, MD

Henry Ford Hospital
Detroit, USA

Invited Faculty: Marvin Eng, MD
Marvin H. Eng MD graduate from Wayne State School of Medicine and completed his internal medicine and general cardiology training at the University of Colorado Health Sciences Center. Subsequently, Dr. Eng completed his interventional cardiology training at the Scripps Clinic in La Jolla, California.  His first faculty appointment was at the University of Texas Health Sciences Center-San Antonio where he started the TAVR program at the University.  Since arriving back in Detroit in 2015, Dr. Eng currently serves as the Structural Heart Disease (SHD) Fellowship and the SHD research director.  His focus includes imaging, large bore access, TAVR and mitral interventions.   

Peter J. Fitzgerald, MD

Stanford University
Stanford
United States of America

Invited Faculty: Peter J. Fitzgerald, MD
More

Peter J. Fitzgerald, MD

Stanford University
Stanford, United States of America

Invited Faculty: Peter J. Fitzgerald, MD
Dr. Peter Fitzgerald, MD, PhD, FACC, is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor in both the Departments of Medicine and Engineering (by courtesy) at Stanford.

Presently, Dr. Fitzgerald’s laboratory includes 17 postdoctoral fellows and graduate engineering students focusing on state-of-the-art technologies in Cardiovascular Medicine. He has led or participated in over 150 clinical trials, published over 450 manuscripts/chapters, and lectures worldwide. He has trained over 150 post-docs in Engineering and Medicine in the past decade. In addition, he heads the Stanford/Asia MedTech innovation program.

Peter has been principle/founder of twenty-one medical device companies in the San Francisco Bay Area. He has transitioned fourteen of these start-ups to large medical device companies. He serves on several boards of directors, advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Peter was on the founding team of LVP Capital, a venture firm, focused on medical device and biotechnology start-ups in San Francisco. In 2009, he co-founded TriVentures, which is an incubator/venture fund for early stage medical technology in Israel.

James Freeman, MD

Yale School of Medicine
New Haven
United States of America

Invited Faculty: James Freeman, MD

Edward P. Gerstenfeld, MD

University of California San Francisco
San Francisco
USA

Invited Faculty: Edward P. Gerstenfeld, MD

Eberhard Grube, MD

Heart Center Bonn
Bonn
Germany

Invited Faculty: Eberhard Grube, MD
More

Eberhard Grube, MD

Heart Center Bonn
Bonn, Germany

Invited Faculty: Eberhard Grube, MD
Prof. Grube is Professor of Medicine, Head, Center of Innovative Interventions in Cardiology (CIIC)University Hospital Bonn,Germany and Consulting Professor, Division of Cardiovascular Medicine, at Stanford University School of Medicine.
He received his first degree in Medicine at the Rheinische Friedrich-Wilhelm-University in Bonn. His cardiology training was completed at University of Wisconsin, Medical School and University of Bonn, Medical School.
He received his Board Certification in Internal Medicine, in Cardiology and in Angiology from the North Rhine Chamber of Medical Doctors and his post-doctoral lecturing qualification “Internal Medicine“ from the Rheinische Friedrich-Wilhelm-University in Bonn.
He is a fellow of the American College of Cardiology, the American College of Angiology and the Society for Cardiac Angiography & Interventions.

His research interest include drug eluting stents, distal protection devices, debulking devices, restenosis and in-stent restenosis.

Rebecca Hahn, MD

New York Presbyterian Hospital / Columbia University Medical Center
New York City
USA

Invited Faculty: Rebecca Hahn, MD
More

Rebecca Hahn, MD

New York Presbyterian Hospital / Columbia University Medical Center
New York City, USA

Invited Faculty: Rebecca Hahn, MD
Education
  • 9/1976 – 6/1980    B.A. Biology, Harvard University
  • 9/1980 – 6/1984    M.D. Medicine, Washington University/St. Louis    

Internship and Residency
  • 7/1984 – 6/1985    Intern, Internal Medicine, New York Hospital/Cornell
  • 7/1985 – 6/1987    Resident, Internal Medicine, New York Hospital/Cornell
  • 7/1986 – 6/1987    Asst. Chief Resident, Internal Medicine, New York Hospital/Cornell

Clinical and Research Fellowships
  • 7/1987 – 6/1989    Fellow, Cardiology, New York Hospital/Cornell
  • 7/1989 – 6/1990    Research Fellow, Cardiology, New York Hospital/Cornell

Licensure/Certification
  • 9/1985 New York State License Registration #163707
  • 9/1987 Diplomate, American Board of Internal Medicine (#112847)
  • 11/1989 Diplomate, American Board of Internal Medicine (#112847), Cardiovascular Disease Subspecialty
  • 6/1997 National Board of Echocardiography
  • 6/2007 National Board of Echocardiography Recertification

Academic Appointments
  • 7/1989 – 6/1990 Clinical Instructor/Medicine, Weill Medical/Cornell University
  • 7/1990 – 6/1993 Assistant Prof. of Clinical Medicine, Columbia College of P&S
  • 7/1993 – 6/1999 Assistant Prof. of Medicine. Weill Medical/Cornell University
  • 7/1999 – 10/2003 Associate Prof. of Medicine, Weill Medical/Cornell University
  • 10/2003-2/2007 Associate Prof. of Medicine, New York University
  • 4/2007-present Associate Prof. of Medicine at Columbia University College of Medicine

Hospital Appointments
  • 7/1990 – 6/1993 Assistant Attending Physician, St. Luke’s/Roosevelt Hospital
  • 7/1993 – 10/2003 Associate Attending Physician, New York Presbyterian Hospital
  • 10/2003 – 10/2007 Attending Physician, North Shore University Hospital
  • 4/2007- present Attending Physician NY Presbyterian Hospital

Awards and Honors
  • 1979 and 1980 All-American: Women’s Squash
  • 7/1983 Irwin Levy Prize in Neurology and Neurologic Surgery Award
  • 7/1984 American Medical Women’s Association, Inc. Scholarship Achievement Citation
  • 7/1984 Alpha Omega Alpha
  • 6/2009 Richard Popp Excellence in Teaching Award, American Society of Echocardiography
  • 4/2010-present Fellow of the Apgar Academy of Medical Educators (formerly Glenda Garvey Teaching Academy), Columbia University School of Medicine

Professional Memberships

  • 1/2009-present Fellow, American Society of Echocardiography
  • 11/1989-present Fellow, American College of Cardiology
  • 7/1990-present Member, American Society of Echocardiography
  • 7/1990-present Member, American Heart Association
  • 7/1994 Member, International Society for Adult Congenital Cardiac Disease

Administrative Responsibilities

  • 7/1999 – 10/2003 Clinical Director Echocardiography, New York Presbyterian Hospital
  • 10/2003 – 2/2007 Director of Echocardiography, North Shore University Hospital
  • 7/2007 – 7/2010 Associate Director Valve Center (Noninvasive) Columbia University
  • 7/2007—7/2010 Associate Director Echocardiography and Vascular Ultrasound Core Laboratory
  • 7/2010- present Director of Interventional Echocardiography, Center for Interventional Vascular Therapy, Columbia University
  • 9/12/2012-present Echo Director, Cardiovascular Research Foundation: responsible for providing high quality and cost effective Echocardiography interpretation services and enhancing the quality and quantity of the academic output related to the ECHO Core Laboratory in support of the education and research mission of CRF

David Holmes, MD

Mayo Clinic
Rochester
USA

Invited Faculty: David Holmes, MD
More

David Holmes, MD

Mayo Clinic
Rochester, USA

Invited Faculty: David Holmes, MD
Dr. Holmes is currently a Professor of Medicine at the Mayo Clinic College of Medicine and a consultant in the Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota. Dr. Holmes has also been named the Edward W. and Betty Knight Scripps Professor in Cardiovascular Medicine in Honor of Dr. George M. Gura, Jr.  He was awarded an Honorary Fellowship of the Royal College of Physicians in Ireland in November 2011.  He has received the Distinguished Scientist Award (Clinical Domain) from the American College of Cardiology and the Research Career Achievement Award from the Mayo Graduate School of Medicine.  He is a Past President of the American College of Cardiology (ACC) as well as the Society for Cardiac Angiography and Interventions (SCAI).  He has lectured widely both nationally and internationally.  He has received the Herrick Award from the American Heart Association.     

His special areas of interest include acute coronary syndromes, interventional cardiology, restenosis, vascular biology, and risk outcomes analysis.  In addition, he has been involved in the development of new catheter designs for stroke prevention using left atrial appendage occlusion technology.  He has been involved with the introduction and dispersion of transcatheter aortic valve replacement in the United States working with both ACC and the Society for Thoracic Surgery (STS).  As part of that, he has been involved with regulatory agencies including FDA and CMS.  This collaboration has led to the development of a working group on Early Feasibility Studies (EFS).  Finally, he is involved in the development of continued application of percutaneous coronary intervention technology to noncoronary vascular beds.

Dr. Holmes received his medical degree at Medical College of Wisconsin in Milwaukee and completed his internship at Virginia Mason Hospital in Seattle.  He also served in the United States Navy at the National Naval Medical Center in Bethesda.

Michael Hope, MD

University of California San Francisco
San Francisco
USA

Invited Faculty: Michael Hope, MD
More

Michael Hope, MD

University of California San Francisco
San Francisco, USA

Invited Faculty: Michael Hope, MD
Michael D. Hope, MD, is an Associate Professor in Residence in the Department of Radiology at UCSF. He obtained his medical degree from Stanford in 2004. The following year, he did a Medicine internship at California Pacific Medical Center. Dr. Hope completed his Diagnostic Radiology residency at UCSF in 2009, followed by a fellowship in Cardiopulmonary Imaging. He is the Co-Director of the Vascular Imaging Research Center at UCSF, Chair of the MR Safety Committee, and increasingly recognized as an expert in advanced cardiovascular imaging techniques with over 50 invited lectures and 70 peer-reviewed papers, which have been cited over 1,700 times.

Dr. Hope was recently awarded an R01 grant entitled, "Hemodynamic and inflammatory imaging in evaluation of abdominal aortic aneurysms" (R01HL123759). His long-term goal is to expand significantly the role of MR vessel and blood flow imaging in the clinical management of patients with cardiovascular disease.

Expertise:
Cardiac, Aortic and Pulmonary Imaging

Specialty:
Advanced Aortic Imaging
4D Flow Vascular Imaging

Professional Interests:
MR vessel wall and blood flow imaging in the clinical management of patients with cardiovascular disease

Education and Training:
• Medical School: Stanford University School of Medicine, California
• Internship: California Pacific Medical Center, San Francisco
• Residency: University of California, San Francisco
• Fellowship: University of California, San Francisco - Cardiopulmonary Imaging
• California Medical License
• American Board of Radiology, Certificate in Diagnostic Radiology

Jonathan Hsu, MD

University of California San Diego
San Diego
USA

Invited Faculty: Jonathan Hsu, MD
More

Jonathan Hsu, MD

University of California San Diego
San Diego, USA

Invited Faculty: Jonathan Hsu, MD
Jonathan Hsu, MD, is board-certified cardiologist who subspecializes in electrophysiology. He takes care of patients with all types of fast (tachycardia), slow (bradycardia), and irregular heart rhythm disorders, including both atrial and ventricular arrhythmias.

Dr. Hsu strives to give excellent care to his patients by providing open communication and individualized treatment. He makes every effort to provide evidence-based care while also striving to ensure patient satisfaction.

Dr. Hsu has a strong interest in both medical and procedural management of atrial fibrillation (Afib or AF), atrial flutter (AFL), supraventricular tachycardia (SVT), premature ventricular contractions (PVCs), ventricular tachycardia (VT), ventricular fibrillation (VF), and syncope. He is skilled at catheter ablation for arrhythmia treatment, including the more common arrhythmias such as atrial fibrillation, atrial flutter, premature ventricular contractions, ventricular tachycardia and supraventricular tachycardia. Dr. Hsu treats all types of supraventricular tachycardias, including atrioventricular nodal reentrant tachycardia (AVNRT), atrioventricular reentrant tachycardia (AVRT), Wolff- Parkinson-White (WPW) syndrome, atrial tachycardia (AT), and junctional tachycardia (JT). He is also an expert in specific heart rhythm syndromes including Long QT syndrome, Hypertrophic Cardiomyopathy (HOCM or HCM), Brugada Syndrome, Arrhythmogenic Right Ventricular Dysplasia / Cardiomyopathy (ARVD or ARVC), as well as arrhythmias related to coronary artery disease (CAD), congenital heart disease and cardiac sarcoidosis.

Besides using catheter ablation to treat atrial fibrillation, Dr. Hsu also has a special interest in stroke reduction in patients with AF using warfarin (Coumadin) or newer blood thinners (non-vitamin K antagonist oral anticoagulants). He is trained and able to perform newer procedural techniques for left atrial appendage (LAA) exclusion, including the WATCHMAN left atrial appendage occlusion device and epicardial ligation of the left atrial appendage with the LARIAT device.

Dr. Hsu's expertise also includes implantation and management of cardiac rhythm devices, including implantable loop recorders, pacemakers, implantable-cardioverter defibrillators, and cardiac resynchronization therapy [CRT] (biventricular [BiV]) devices.

As an associate professor in the Department of Medicine, Dr. Hsu educates and mentors medical students, residents and fellows. He is also a clinical research investigator with advanced training, and his interests include epidemiology and clinical outcomes in patients with all types of cardiac arrhythmias. Dr. Hsu's research has resulted in publications in medical journals such as The New England Journal of Medicine, as well as several top cardiology journals, including Journal of the American College of Cardiology and Circulation.

He completed a residency in internal medicine at Massachusetts General Hospital and fellowship training in general cardiology and advanced subspecialty training in cardiac electrophysiology at UCSF School of Medicine, where he also obtained a master’s degree in clinical research. Dr. Hsu earned his medical degree from Northwestern University Feinberg School of Medicine. He is board certified in internal medicine, cardiovascular disease and clinical cardiac electrophysiology.

Dr. Hsu has achieved fellow status at the top cardiology and cardiac rhythm societies, including distinction as a fellow of the American College of Cardiology (FACC), fellow of the American Heart Association (FAHA), and fellow of the Heart Rhythm Society (FHRS).

Henry Huang, MD

Rush University
Chicago
United States of America

Invited Faculty: Henry Huang, MD

Reda Ibrahim, MD

University of Montreal, Institut of Cardiology
Montreal
Canada

Invited Faculty: Reda Ibrahim, MD
More

Reda Ibrahim, MD

University of Montreal, Institut of Cardiology
Montreal, Canada

Invited Faculty: Reda Ibrahim, MD
Dr Reda Ibrahim is a cardiologist at the Montreal Heart Institute and an Associate Professor at the University of Montreal. He studied Internal Medicine and Cardiology at the University of Montreal. In 2001-2002, he conducted a subspecialty in adult congenital and structural interventions at the Brigham and Women and Children's Hospitals of Harvard University in Boston. Dr. Ibrahim is the Medical Director of the Structural Heart Diseases Program since 2014 and is the former Director of the Medical Intensive Care Unit (2006-2014). He has won several awards and honors including the professor of the year from the Department of Medicine in 2004 and 2005. In term of research, he was the principal investigator of several important studies (CLOSURE-1, PC-trial, RESPECT, PRIMA, REDUCE, etc.). As other achievements, he has many publications, numerous presentations in major congresses (TCT, EuroPCR, PICS, CSI, AHA, ACC-i2 Summit, ESC), a number of Canadian and North American premieres, live proceedings at various conferences (ACC-TCT-EuroPCR-PICS-ISLAA), and "proctor" activities for different companies.

Frank Ing, MD

University of California Davis
Davis
USA

Invited Faculty: Frank Ing, MD

Maxim Itkin, MD

University of Pennsylvania Medical Center/Children's Hospital of Philadelphia
Philadelphia
United States of America

Invited Faculty: Maxim Itkin, MD
More

Maxim Itkin, MD

University of Pennsylvania Medical Center/Children's Hospital of Philadelphia
Philadelphia, United States of America

Invited Faculty: Maxim Itkin, MD
Bio:
Dr. Itkin is a Professor of Radiology and Pediatrics at the University of Pennsylvania and where he is a director of the Center for Lymphatic Imaging and Interventions.
 
Dr. Itkin is nationally and internationally recognized for his clinical and research expertise in an interventional treatment of the lymphatic disorders.  Over the past 15 years, Dr. Itkin has been actively involved in the development of image-guided interventions of the lymphatic system (Thoracic Duct Embolization, liver lymphatic embolization, interstitial lymphatic embolization etc.) as a treatment of lymphatic disorders. Dr. Itkin developed intranodal lymphangiogram, as a substitute pedal lymphangiogram. This method  opened new horizons for lymphatic interventions.

Dr. Itkin developed contrast enhanced MR lymphangiogram for non-invasive dynamic imaging of the lymphatic anatomy. This technique led to the discovery of pathophysiology and treatment of plastic bronchitis, neonatal chylothorax, congenital lymphodysplasia and protein loosing enteropathy.

Dr. Itkin has lectured extensively nationally and internationally and has 90 peer reviewed publications, reviews and editorials in leading journals. He is a member of many national and international professional societies and in 20011 was inducted into the Society of the Interventional Radiology as a Fellow member as recognition of significant contributions to the field of cardiovascular and interventional radiology.


Saibal Kar, MD

Cedars Sinai Medical Center
Los Angeles
USA

Invited Faculty: Saibal Kar, MD

Ahmed Kheiwa

University of California San Francisco
San Francisco
USA

Invited Faculty: Ahmed Kheiwa

Liviu Klein, MD

University of California San Francisco
San Francisco
United States of America

Invited Faculty: Liviu Klein, MD

Jayanthi Koneru , MD

VCU Health
Virginia
United States of America

Invited Faculty: Jayanthi Koneru , MD

Raghavannair Suresh Kumar, MD

National Heart Centre, Royal Hospital
Muscat
Oman

Invited Faculty: Raghavannair Suresh Kumar, MD
More

Raghavannair Suresh Kumar, MD

National Heart Centre, Royal Hospital
Muscat, Oman

Invited Faculty: Raghavannair Suresh Kumar, MD
●    Post graduate teacher in cardiology in Medical Colleges of Kerala. 1983 – 1991
●    Consultant at  the first comprehensive paediatric cardiac service in UAE at the Mafraq Hospital, Abu Dhabi, 1991 – 2004
●    Head of Paediatric Cardiology  at The Madras Medical Mission, Chennai and Frontier Lifeline, Chennai,India. 2004 – 2014
●    Course Director  at Advanced Cardiovascular Therapeutics, The Madras Medical Mission, Chennai. 2006 – 2012 .
●    Invited Speaker ,UCSF Cardiology Grand Rounds,April 13.2016
●    Author of over 30 publications and several text book chapters.
●    E-teacher for paediatric cardiology residents worldwide

Dhanunjaya Lakkireddy, MD

University of Kansas Hospital
Kansas City
USA

Invited Faculty: Dhanunjaya Lakkireddy, MD

Scott Lilly

Ohio State University Wexner Medical Center
Columbus, OH
United States of America

Invited Faculty: Scott Lilly
More

Scott Lilly

Ohio State University Wexner Medical Center
Columbus, OH, United States of America

Invited Faculty: Scott Lilly
Scott M. Lilly, MD, PhD, FACC, FSCAI is an interventional cardiologist and Associate Professor of Internal Medicine within the Division of Cardiology at The Ohio State University Wexner Medical Center.  He is also the interventional director of their Structural Heart Program. 

He earned his medical degree and doctor of philosophy from the University of Toledo, where he received both a National Research Service Award and the Graduate Dean's Award.  He completed internal medicine and general cardiology training at the Hospital of the University of Pennsylvania.  While there, he also received advanced training in the invasive treatment of coronary and structural heart disease.  He has been the recipient of multiple teaching awards as both a fellow and faculty member. 

He has a particular interest structural heart therapies for valvular heart disease and heart failure.  He numerous peer-reviewed articles and book chapters on atherosclerosis and structural heart therapies.  He is sits on several committees for the American College of Cardiology, is a frequent presenter at local and national meetings and holds editorial roles for medical journals and online healthcare media.  

Liwen Liu

Xijing Hospital, Fourth Military Medical University
Xi'an
China

Invited Faculty: Liwen Liu

Gurol Mahmut Edip, MD

Massachusetts General Hospital
Massachusetts
United States of America

Invited Faculty: Gurol Mahmut Edip, MD

Raj Makkar, MD

Cedars-Sinai Medical Center
Los Angeles
USA

Invited Faculty: Raj Makkar, MD

Greg Marcus, MD

University of California San Francisco
San Francisco
United States of America

Invited Faculty: Greg Marcus, MD

Jeffrey Meadows, MD

University of California San Francisco
San Francisco
USA

Invited Faculty: Jeffrey Meadows, MD
More

Jeffrey Meadows, MD

University of California San Francisco
San Francisco, USA

Invited Faculty: Jeffrey Meadows, MD
Dr. Meadows is a pediatric cardiologist who specializes in interventional cardiac catheterization procedures in infants, children and adults with complex congenital and acquired heart disease. Dr. Meadows is Director of the Pediatric & Congenital Cardiac Catheterization Laboratory at the UCSF Benioff Children’s Hospital where he also serves as Director of the Pediatric Cardiopulmonary Exercise Testing Program.
 Dr. Meadows is an associate professor in the UCSF Division of Pediatric Cardiology. He earned a medical degree at Johns Hopkins University and completed an internship and residency in pediatric internal medicine and fellowships in pediatric cardiology and pediatric interventional cardiology at Children's Hospital in Boston. Dr. Meadows as also completed advanced training in biostatistics and clinical study design through the UCSF Department of Epidemiology and Biostatistics.

John Moore, MD

Rady Children's Hospital-San Diego
San Diego
United States of America

Invited Faculty: John Moore, MD
More

John Moore, MD

Rady Children's Hospital-San Diego
San Diego, United States of America

Invited Faculty: John Moore, MD
John W. Moore, MD, MPH is a distinguished graduate of the United States Military Academy, Harvard Medical School and Harvard School of Public Health.  He is the Medical Director of Cardiology at Rady Children’s Hospital – San Diego and Professor of Pediatrics and Chief of the Section of Pediatric Cardiology at the University of California, San Diego School of Medicine.   He has served as Chairman of the Executive Committee of the American Academy of Pediatrics, Section on Cardiology and Cardiac Surgery and as the Cardiology Representative on The Pediatric Advisory Committee to the U.S. Food and Drug Administration.  Dr. Moore is the Medical Editor of Congenital Cardiology Today and an Associate Editor of Congenital Heart Disease.  He also serves on the Editorial Boards of the American Journal of Cardiology and The Journal of Invasive Cardiology. Dr. Moore’s major clinical and research focus is in the area of congenital and structural interventional cardiology.

Philip Moore, MD

University of California San Francisco
San Francisco
United States of America

Invited Faculty: Philip Moore, MD

Marouche Nassir, MD

Health University of Utha
Utha
United States of America

Invited Faculty: Marouche Nassir, MD

Keshav Nayak, MD

Scripps Health
San Diego
United States of America

Invited Faculty: Keshav Nayak, MD
More

Keshav Nayak, MD

Scripps Health
San Diego, United States of America

Invited Faculty: Keshav Nayak, MD
CURRICULUM VITAE

Keshav R. Nayak, MD CAPT USN MC

Director, Cardiac Cathlabs, Staff Interventional Cardiologist

Naval Medical Center San Diego (NMCSD), San Diego, CA 92134

EDUCATION

Year Degree Institution

1997 M.D PENNSTATE UNIV SOM

1993 B.S HAVERFORD COLLEGE

POST GRADUATE EDUCATION

Year Position Institution

2009 INTV FELLOWSHIP SCRIPPS CLINIC
2006 FELLOWSHIP NMCSD CARDIOLOGY
2003 RESIDENCY NMCSD INTERNAL MEDICINE
1998 INTERNSHIP NMCSD INTERNAL MEDICINE

ACADEMIC APPOINTMENTS

Year Position Institution

2017 ASSOCIATE PROF USUHS
2012 ASSISTANT PROF USUHS

OTHER EMPLOYMENT PERTAINING TO CURRENT PROFESSIONAL APPOINTMENT

A. Director, Cardiac Catheterization Laboratory, NMCSD July 2010-Present
Staff Interventional Cardiologist, NMCSD July 2009-Present

1. Senior-most structural and coronary interventionalist in Navy cardiology.

2. Created first military structural heart interventional program: successfully planned and rolled out first Trans-catheter Aortic Valve Replacement (TAVR), CTO, LAAC, program in Dept. of Defense (DoD).

3. Designed and built NMCSD’s state of the art Hybrid Operating Room cath lab suite which facilitated partnership with San Diego VA for combined Navy-VA TAVR/structural interventional program. Expertise in wide range of procedures with primary focus on
a. Adult congenital lesions: ASD/PDA/coronary fistula repair and PFO repair especially in Military Divers.
b. Structural heart interventions: TAVR, mitral and aortic valvuloplasty, and LAA occlusion.
c. CTO, Protected (Impella) and Complex PCI (rotational and laser atherectomy).

4. Active proposal to DHA/BUMED for NMCSD to be designated Navy Medicine West/DoD’s Heart and Vascular Center of Excellence.
B. Visiting Faculty in India/Vietnam Feb 2010-Present

1. Annual humanitarian visits to India and Vietnam as staff structural interventionalist for personal focus on global cardiovascular disease and health equity.
2. Perform high volume coronary interventions, mitral valvuloplasty, congenital heart interventions (ASD/VSD, PDA/RSOVA, and coronary fistula repair) for patients without access to care.
3. Awarded $350,000 Asia Pacific Regional initiative grant for Vietnam in 2011.
4. Active application to PACOM and Navy Global Health Engagement (GHE) office for FY18 INDIA GHE OHASIS Interventional Cardiology SMEE.
5. Country expert for Global cardiovascular conditions in India/Vietnam

C. Staff interventional Cardiologist, Sharp Mem. Hospital July 2009-Present

1. Visiting interventional privileges for TAVR, high risk PCI, STEMI/CS, valvuloplasty, ASD repair at San Diego tertiary level Heart hospital.

D. Staff Interventional Cardiologist, Rady’s Children’s Hospital July 2014-Present

1. Assisting interventional privileges for pediatric and adult congenital procedural experience such as Melody trans-catheter heart valve procedures, ASD closures, and congenital heart procedures on Navy pediatric and young adult beneficiaries referred to local Children’s hospital for complex congenital heart lesions.

E. Director, Cardiac Research, NMCSD July 2009-Present

1. Developed Cardiology fellowship scholarly activity curriculum that increased scholarly activity resulting in multiple IRB approved protocols, presentations at regional, national, and international meetings as well as publications in peer reviewed journals allowing for recurring citation free ACGME fellowship accreditations.

F. Chairman, Executive Committee of Medical Staff, NMCSD Oct ‘10-Feb ‘13

1. Primary advisor to COO on all medical staff matters ranging from staff credentials, quality metrics and medical staff policies with direct oversight of 10 medical staff sub-committees.

G. Medical Director, Vista Free Medical Camp 2006-Present

1. Medical Director of annual free medical camp in North County serving uninsured, indigent patient population.

H. SCAI Emerging Leadership Fellow Award 2017-2019

1. Recipient of prestigious national fellowship award to facilitate transition into the next generation of great thinkers, presenters, teachers, and national leaders.

I. Staff Interventional Cardiologist, Scripps Mercy 2018-Present

1. Staff interventional privileges for STEMI/ACS/Shock PCI at regional STEMI receiving center.

Alan Nugent

Lurie Children’s Hospital
Chicago, IL
USA

Invited Faculty: Alan Nugent
More

Alan Nugent

Lurie Children’s Hospital
Chicago, IL, USA

Invited Faculty: Alan Nugent
Dr Nugent trained in pediatrics and pediatric cardiology at the Royal Children’s Hospital in Melbourne Australia and completed fellowship in pediatric cardiology at Boston Children’s Hospital. He is currently the Director of Catheterization at Children’s Health Dallas and an Associate Professor Department of Pediatrics at UT Southwestern Medical Center. At UTSW he has been the lead investigator in testing biodegradable stents for congenital heart disease applications.

Eustaquio Maria Onorato , MD

Humanitas Gavazzeni Clinic
Bergamo
Italy

Invited Faculty: Eustaquio Maria  Onorato , MD
More

Eustaquio Maria Onorato , MD

Humanitas Gavazzeni Clinic
Bergamo, Italy

Invited Faculty: Eustaquio Maria  Onorato , MD
•    Medical Degree with honours
University of Milan, Milan School of Medicine, Italy (1977)
University of Zulia, Maracaibo School of Medicine, Venezuela (1980)

•    First Class Degree Certification, Cardiology
Post Graduate Course in Cardiology, University School of Medicine, Caracas, Venezuela (1984)

•    Degree Certification, Paediatric Cardiology
Post Graduate Course in Pediatric Cardiology, University School of Medicine, Caracas, Venezuela (1986)

•    Teaching Assistant Professor
Institute of Cardiology, University Hospital of Caracas, Venezuela (1985-1989)

•    Degree Certification, Radiology
Post Graduate Course in Radiology, University School of Medicine, Siena, Italy (1994).

•    Co-Director of the Cardiovascular Catheterization Laboratory
Centro "E. Malan", San Donato Hospital, University of Milan, Italy (1989-1997)

•    Director of Cardiology Department and Cardiac Catheterization Laboratory
Clinica San Rocco di Franciacorta, Ome, (Brescia), Italy (1997-2002)

•    Director of Cardiology Division I and Cardiac Catheterization Laboratory
Humanitas Gavazzeni Clinic, Bergamo, Italy (2002-2006)

•    Director of Cardiology Department and Cardiac Catheterization Laboratory
Ospedale Sant’Orsola Fatebenefratelli, Brescia, Italy (2006-2009)

•    Teaching Professor, Interventional Cardiology
  Policlinico Universitario Tor Vergata, University School of Medicine, Rome (2010 - 2011)

•    Current position:  Consultant , Interventional Cardiology, Congenital and Structural Heart Diseases
Cardiovascular Department, Humanitas Gavazzeni Clinic, Bergamo
Senior Consultant, Centro Cardiologico Monzino, University School of Medicine, Milan, Italy



•    Scientific Consultant, Proctor and Trainer, Congenital and Structural Interventional Cardiology;
•    Scientific Consultant, Proctor and Trainer, Intracardiac Ultrasound for catheter-based interventional procedures
Centro Cardiologico Monzino, University School of Medicine, Milan, Italy
    Clinica Montevergine, Mercogliano, Italy
    S.Anna Hospital, Catanzaro, Italy
    Presidio Ospedaliero San Giovanni di Dio, Agrigento
    Presidio Ospedaliero “S.Elia”, Caltanissetta
    Bakulev Scientific Center for Cardiovascular Surgery, Moscow Medical Academy, Russian Federation
    Republican Cardiology Center – Ufa, Republic of Bashkiria, Russian Federation
    Cardiology Institute, Kazan, Republic of Tatarstad, Russian Federation
    Cardiology Dept, Santariskiu Klinikos, University School of Medicine, Vilnius, Lithuania
    Centru Cardiovascular, Spitalul Monza – Bucarest, Romania
    Hungarian Institute of Cardiology – Pediatric Cardiac Centre – Budapest, Hungry
    Instituto de Cardiologia, Hospital Universitario de Caracas, University School of Medicine – Caracas, Venezuela
    Instituto Cardiovascular de Buenos Aires, Argentina
    Servicio de Cardiologia – Hemodinamia, Hospital de Los Valles – Quito, Ecuador
    Om El Kora Cardiac Center, University Hospital, Tanta, Egypt
    Pediatric Cardiology, Cairo University Children Hospital, Egypt
    Centre Hospitalier Universitaire (CHU) “Charles Nicole, Rouen, France
    Centre Hospitalier Universitaire (CHU) “Arnaud de Villenueve“, Montpellier, France
    Centre Hospitalier Régional Universitaire de Lille (CHRU), France
    American Heart Institute, Nicosia, Cyprus  



Scientific Society Memberships
National
•    Società Italiana di Cardiologia Pediatrica (SICP)
•    Gruppo Italiano di Studi Emodinamici e Cardiologia Interventistica (G.I.S.E.)
•    Associazione Medici Cardiologi Ospedalieri (A.N.M.C.O.): Fellow
•    Società Italiana di Radiologia Medica (SIRM)
International
•    Sociedad Venezolana de Cardiologia
•    Sociedad Latina de Cardiologia Pediatrica
•    The Society for Cardiac Angiography and Interventions (SCAI): Fellow
•    European Society of Cardiology (ESC): Fellow
•    Russian Scientific Society of Interventional Radiology & Endovascular Surgery: Honorary Membership
•    Sociedad Venezolana de Cardiologia Intervencionista : Honorary Membership


Field of Interest and Clinical Research
Interventional Percutaneous Procedures in Congenital and Structural Heart Diseases in Childrens and Adults:
-    Interatrial communications: atrial septal defect and patent foramen ovale (PFO) closure
-    Ventricular sepal defect closure (perimembranous, muscular)
-    Post-infarction ventricular septal rupture closure  
-    Patent ductus arteriosus closure
-    Pulmonary arteriovenous malformations and coronary artery fistulas closure
-    Paravalvular Leak percutaneous closure
-    Left Atrial Appendage Closure  
-    Balloon Valvuloplasty for pulmonary valve and aortic valve stenosis
-    Other complex congenital heart defects

Xiang-Bin Pan, MD

Beijing Fuwai Hospital
Beijing
China

Invited Faculty: Xiang-Bin Pan, MD

Mehul Patel, MD

Methodist LeBonheur Healthcare
Germantown
United States of America

Invited Faculty: Mehul Patel, MD
More

Mehul Patel, MD

Methodist LeBonheur Healthcare
Germantown, United States of America

Invited Faculty: Mehul Patel, MD
Certifications: ABIM Board Certified in IM, Cardiology, ACHD, Interventional cardiology.

Educational Commission for Foreign Medical Graduates (ECFMG) dated February 15th, 2007

Status: Valid Indefinitely, number 0-711-652-8

USMLE scores: Step 1 – 99, Step 2 CK – 99, Step 2 CSA and step 3 – passed

National Board of Echocardiography: 2014

IBHRE (NASPE) Board certification, CCDS: 2010, valid till June 2020

Full Licenses: TN: 57119 active, NC medical License: 00287 - active; MI Medicine license # 4301090674 - active,

TX medical full license # P8064 – active

Training: Structural Heart Disease – Henry Ford Hospital, Detroit, MI

Adult Congenital Heart disease -Texas Children’s, Texas Heart Institute and BCM, Houston, TX

Interventional Cardiology - Mount Sinai Medical Center, New York City, NY

Cardiology/EP: Michigan State University, Lansing, MI

DNB. Cardiology (National Board of Examinations, India)

M.D. Internal Medicine (King Edward Memorial Hospital, Mumbai University, India)

DNB. Internal Medicine (National Board of Examinations, India)

M.B. B.S (Mumbai University, India)

Work Experience: Current: Director of SHD and Hybrid lab, Methodist LeBonheur Healthcare, Germantown, TN

17 months: Assistant Professor, Assistant director of cath lab; ACHD Interventions and devices
Michigan State University, MI

36 months: Assistant Professor Cardiology (Interventions and EP), Veterans affairs, WSU, Detroit and
USF, Tampa


Academic Honors: Awards for research. PICS AICS 2013 scholarship and best abstract finalist

Gold medals for MD and Cardiology Boards (India)

Membership: Member of the working group committee for GUCH of the European Society of Cardiology

CHiP Network Professional: Co Editor-in-Chief of CHiP Journal watch.

Skills: 1. Clinical: TAVR (Edward Sapien, Evolut R), percutaneous pulmonary valve implantation (Melody valve and
Edwards Sapien valve), MitraClip, percutaneous mitral and tricuspid valve replacement, caval valves, transcaval access for TAVR
and 5.0 Impella, Watchman, Lariat, PVL closure, ASD/PFO/VSD/PDA closures, CoA repair, transbaffle interventions, complex
congenital interventions along with PCI, peripheral interventions (not including carotids and atherosclerotic aortic interventions) and
complex device implantations with venoplasties.

2. Research: Experience with Direct Flow, Portico and Tendyne valves. Certified to do research on large animals
such as Dogs, Sheep and Pigs. Performed acute and chronic survival studies in large animals.

Atif N. Qasim, MD

University of California San Francisco
San Francisco
USA

Invited Faculty: Atif N. Qasim, MD

Vivek Reddy, MD

The Mount Sinai Medical Center
New York City
USA

Invited Faculty: Vivek Reddy, MD

Mark Reisman, MD

University of Washington Medical Center
Seattle
USA

Invited Faculty: Mark Reisman, MD

John F. Rhodes, Jr., MD

Medical University of South Carolina
Charleston
USA

Invited Faculty: John F. Rhodes, Jr., MD
More

John F. Rhodes, Jr., MD

Medical University of South Carolina
Charleston, USA

Invited Faculty: John F. Rhodes, Jr., MD
Dr. Rhodes is “The Heart Program”, Medical Director for Pediatric Cardiology and the Adult Congenital Heart Program at Miami Children’s Hospital.  Prior to joining Miami Children’s, Dr. Rhodes served as chief for the Duke Clinical Heart Program and Duke Children’s Heart Center in Durham, North Carolina.  He was also co-director of the Duke Adult Congenital Heart Program.  
Dr. Rhodes received his medical degree from The Brody School of Medicine in Greenville, North Carolina and completed his fellowship in cardiology at The Mount Sinai Medical Center in New York.  He pursued additional training in interventional catheterization for children and adults at The Cleveland Clinic Foundation in Cleveland.  
Dr. Rhodes’ clinical interests involve diagnostic and interventional catheterization procedures for children and adults with complex congenital heart disease.  He has helped pioneer several techniques, including transcatheter atrial septal closure with the Gore Helex Septal Occluder, intracardiac echocardiographic imaging to guide catheter interventions, cutting balloon angioplasty of stenotic branch pulmonary arteries, and pulmonary vein stenosis following radiofrequency ablation of atrial fibrillation.  He is currently the National Principal Investigator for the REDUCE trial for the management of patent foramen ovale in the setting of cryptogenic stroke and is an investigator for trials including the new Gore Septal Occluder device, Edwards Lifesciences pulmonary stent valve, MELODY pulmonary stent valve, and covered stent angioplasty for coarctation of the aorta.

Charanjit S. Rihal, MD

Mayo Clinic
Rocheste
United States of America

Invited Faculty: Charanjit S. Rihal, MD

Campbell Rogers, MD

HeartFlow, Inc
Redwood City
USA

Invited Faculty: Campbell Rogers, MD
More

Campbell Rogers, MD

HeartFlow, Inc
Redwood City, USA

Invited Faculty: Campbell Rogers, MD
Dr. Rogers brings a wealth of experience to HeartFlow, where he serves as the Executive Vice President and Chief Medical Officer. Prior to joining HeartFlow, he was the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic, and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases, and was the recipient of research grant awards from the NIH and AHA. He received his A.B. from Harvard College and his M.D. from Harvard Medical School.

Carlos E. Ruiz, MD

Hackensack University Medical Center and The Joseph M. Sanzari Children's Hospital
Hackensack
USA

Invited Faculty: Carlos E. Ruiz, MD

Shyam K. Sathanandam, MD

University of Tennessee
Tenessee
USA

Invited Faculty: Shyam K. Sathanandam, MD

Jacqueline Saw, MD

Vancouver General Hospital
Vancouver
Canada

Invited Faculty: Jacqueline Saw, MD
More

Jacqueline Saw, MD

Vancouver General Hospital
Vancouver, Canada

Invited Faculty: Jacqueline Saw, MD
Dr. Jacqueline Saw is an Interventional Cardiologist at Vancouver General Hospital and St Paul’s Hospital, Clinical Associate Professor of Medicine at UBC, and Program Director of the VGH Interventional Cardiology Fellowship Program. She served as Head of VGH Cardiology Clinical Trials Research. She is an active physician proctor for LAA closure with WATCHMAN and ACP/Amulet devices.

Dr. Saw is a pioneer in research and management of spontaneous coronary artery dissection (SCAD) and is the PI of the CIHR-funded multi-center prospective Canadian SCAD Study. Other research interests include LAA closure, coronary fibromuscular dysplasia, antiplatelet therapy, carotid artery stenting, peripheral arterial disease and intervention. She is also PI of PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG, and ELAPSE studies. She has co-authored over 130 peer-reviewed publications, and is the editor of three textbooks on LAA closure and carotid artery stenting.

Nelson B. Schiller, MD

University of California San Francisco
San Francisco
USA

Invited Faculty: Nelson B. Schiller, MD
More

Nelson B. Schiller, MD

University of California San Francisco
San Francisco, USA

Invited Faculty: Nelson B. Schiller, MD
Dr. Nelson B. Schiller is a cardiologist specializing in the use of echocardiography in the diagnosis and treatment of heart disease. He is the founder of the UCSF Echocardiography Laboratory and the UCSF Adult Congenital Heart Disease Clinic. He has played an integral role in the development of many diagnostic and treatment techniques including two dimensional echocardiography, transesophogeal echocardiography, Doppler pulmonary pressure determination, myocardial contrast perfusion and echocardiography phase imaging for ventricular coordination. In structural heart disease areas, he is an expert in the treatment of mitral and aortic valve diseases, hypertrophic cardiomyopathy and congenital heart diseases.

In collaboration with his colleagues, his research interests includes in quantitation of cardiac function and structure, the biology and function of the left atrium, exercise physiology and hemodynamics in heart disease, body composition in heart disease, adult congenital heart disease, three-dimensional reconstruction, echocardiographic contrast agents for quantitation and myocardial perfusion, transesophageal echocardiography, physiology of renal disease, and outcomes in coronary disease as predicted by quantitative phenotyping.

Ashish Shah, MD

St Boniface
Winnipeg
Canada

Invited Faculty: Ashish Shah, MD
More

Ashish Shah, MD

St Boniface
Winnipeg, Canada

Invited Faculty: Ashish Shah, MD
Dr. Ashish Shah is an interventional cardiologist with special interest in adult congenital & structural heart diseases at the St. Boniface Hospital and Assistant Professor of Medicine (Cardiology) at the Max Rady College of Medicine, University of Manitoba, Canada. Dr Shah completed medical and cardiology training in India and UK. He also obtained Doctorate of Medicine (Research) in the Cardiovascular Sciences from the King’s College London. Following completion of training in UK, Dr Shah pursued 3 years advanced interventional cardiology fellowships; 1-year in coronary interventions and 2-years in adult congenital and structural heart diseases at the Toronto General Hospital, Canada. 

In his current position, Dr Shah has joined as a Clinician Scientist and is interested in pursuing outcome research in structural and congenital heart diseases. He is also interested in evaluating flow-mediated cardiovascular diseases. He is involved in collaborative research and setting up a biobank for patients with congenital heart diseases. In addition to clinical work, Dr Shah is also interested in bio-design and has submitted patent applications. 

Wade Smith, MD

University of California San Francisco
San Francisco
United States of America

Invited Faculty: Wade Smith, MD

Kirstin Tolstrop




Invited Faculty: Kirstin Tolstrop

Mintu P. Turakhia, MD

Stanford University School of Medicine
Stanford
USA

Invited Faculty: Mintu P. Turakhia, MD
More

Mintu P. Turakhia, MD

Stanford University School of Medicine
Stanford, USA

Invited Faculty: Mintu P. Turakhia, MD
Associate Professor
Executive Director, Center for Digital Health
Stanford University School of Medicine

Chief of Cardiac Electrophysiology, VA Palo Alto Health Care System

Mintu Turakhia M.D. M.A.S. is a cardiac electrophysiologist, outcomes researcher, and clinical trialist. In his clinical role as Chief of EP at the VA, Dr. Turakhia performs invasive procedures such as catheter ablation and device implantation to treat heart rhythm disorders. Dr. Turakhia has an active, highly-funded multidisciplinary program in Atrial Fibrillation, where uses large datasets to examine quality, outcomes, and risk prediction for heart rhythm disorders. As the Executive Director of Stanford’s new Center for Digital Health, he is the principal investigator of several multi-center trials to test digital health tools and wearable devices to screen and manage heart rhythm disorders. Dr. Turakhia is a Fellow of the American Heart Association, American College of Cardiology, and Heart Rhythm Society.

Dee Dee Wang, MD

Henry Ford Heart and Vascular Institute
Detroit
USA

Invited Faculty: Dee Dee Wang, MD
More

Dee Dee Wang, MD

Henry Ford Heart and Vascular Institute
Detroit, USA

Invited Faculty: Dee Dee Wang, MD
Dee Dee Wang, M.D., FACC, FASE, FSCCT  specializes in Interventional Imaging in Structural Heart Interventions including Transcatheter mitral valve replacement therapies, tricuspid interventions, mitral e-clip, complex TAVRs/adult-congenital cases, LAA interventions, and ASD/PFO closures.
Dr. Wang’s research interests are focused on advancing patient safety and procedural outcomes utilizing 3D+4D imaging for high-risk Structural Heart Interventions. She is currently the Director of Structural Heart Imaging at Henry Ford Hospital’s Center for Structural Heart Disease, Medical Director of 3D Printing at Henry Ford Innovations Institute, and Director of the  CT CoreLab at Henry Ford Hospital’s Center for Structural Heart Disease.

Brian Whisenant, MD

Intermountain Healthcare
Muray
United States of America

Invited Faculty: Brian Whisenant, MD
More

Brian Whisenant, MD

Intermountain Healthcare
Muray, United States of America

Invited Faculty: Brian Whisenant, MD
Dr. Brian Whisenant is an interventional cardiologist and director of the Intermountain Heart Institute Structural Heart Disease program in Salt Lake City. A graduate of Columbia University's College of Physicians and Surgeons, Dr. Whisenant trained in internal medicine at the Beth Israel Hospital in Boston. He completed fellowships in cardiology and interventional cardiology at the University of California San Francisco, and an additional fellowship in interventional cardiology at the Beth Israel Hospital in Boston

David Wilber, MD

Loyola University Medical Center
Maywood
USA

Invited Faculty: David Wilber, MD
More

David Wilber, MD

Loyola University Medical Center
Maywood, USA

Invited Faculty: David Wilber, MD
David Wilber, MD, FAHA, FACC, George M. Eisenberg Professor of Medicine and director, Electrophysiology Section and Cardiovascular Institute, Loyola University Medical Center. Dr. Wilber received his medical degree from Northwestern University Medical School and completed his residency in Internal Medicine at Northwestern Memorial Hospital. He completed his fellowship in cardiovascular disease at the University of Michigan Hospitals and a fellowship in Clinical Cardiac Electrophysiology at Massachusetts General Hospital. His career clinical and research interests have focused on risk stratification and prevention of sudden cardiac death, and mechanisms and ablation of ventricular tachycardia and atrial fibrillation. He has been named annually to Top Doctors in Chicago and the US since 2001. Dr. Wilber is the author or coauthor of more than 500 original articles, book chapters and abstracts, and has served on the steering committee for several multicenter clinical trials.

Evan Michael Zahn, MD

Cedars-Sinai Heart Institute
Los Angeles
USA

Invited Faculty: Evan Michael Zahn, MD
More

Evan Michael Zahn, MD

Cedars-Sinai Heart Institute
Los Angeles, USA

Invited Faculty: Evan Michael Zahn, MD
Evan Michael Zahn, MD, is Co-Director of the Guerin Family Congenital Heart Program in the Heart Institute and Department of Pediatrics and the Director of Pediatric Cardiology at Cedars-Sinai. He is board certified in pediatric cardiology.

Dr. Zahn joined Cedars-Sinai from Miami Children’s Hospital, where he served as Chief of Cardiology and Head of Interventional Catheterization Services for the Congenital Heart Institute.  In 2002, he helped found the Congenital Heart Program at Arnold Palmer Children’s Hospital in Orlando, where he served as director until 2011.

Dr. Zahn’s research focus has been the development and implementation of several important interventional procedures, including several hybrid approaches for the treatment of complex congenital problems, stent implantation in infants and neonates, and complex interventions performed in the early post-operative period. Dr. Zahn participated in the design and development of several devices and FDA clinical trials, resulting in the approval of the Helex septal occluder and the Melody trans-catheter pulmonary valve. He is participating in the COMPASSION clinical trial, which is examining the role of the Sapien trans-catheter valve in the pulmonary position.

In addition to publishing more than 55 articles in peer reviewed journals, Dr. Zahn is a reviewer for the American Journal of Cardiology, Circulation, Catheterization and Cardiovascular Interventions, Congenital Heart Disease and the Journal of the American College of Cardiology. He has authored several book chapter dealing with advanced interventional catheterization techniques for children.  A well-sought after speaker, Dr. Zahn has been invited to lecture at more than 130 conferences, nationally and internationally and has presented numerous abstracts.

Dr. Zahn is a member of the subsection of the American Heart Association’s Cardiovascular Disease in the young and a fellow of the American College of Cardiology and the Society for Cardiac Angiography and Intervention.

After earning a bachelor’s degree at The State University of New York at Albany, Dr. Zahn earned his medical degree at New York Medical College in Valhalla, New York. He completed his pediatric internship and residency at The University of Colorado Affiliated Hospitals in Denver, followed by a pediatric cardiology clinical fellowship and an interventional cardiac catheterization fellowship at the Hospital for Sick Children in Toronto, Canada.
CSI   CSI
Contact Data Privacy Imprint Home CSI 2018 Visit us on Facebook Visit us on Twitter